Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with real-time market insights and portfolio modeling.

Bristol-Myers Squibb Company
vs
 
Pfizer Inc.
 
Bristol-Myers Squibb Company
vs
 
Pfizer Inc.
Performance Comparison
Financial Metrics
BMY Metrics PFE
$49.2 Price $25.74
100.27 Billion Market Capitalization 146.33 Billion
16.6 Price to Earnings Ratio 14.9
5.4 Price to Book Ratio 1.58
2.09 Price to Sales 2.33
6.55 Price to Cash Flow Ratio 14.1
2.77% Revenue Annual Growth -5.92%
81.75% Income Annual Growth -20.84%
71.89% Gross Profit Margin 74.95%
18.01% Net Profit Margin 21.26%

Outperform

28
Underperform
Outperform
AI Model Recommendation

Underperform

-42
Underperform
Outperform
Recommendation Summary

Stock BMY is projected to outperform the market, stock PFE is projected to underperform the market. Upfront Recommendation: BMY.

Stock Comparison
Proprietary AI Model

Proprietary AI Model

Cumulative Return Analysis

Top Holdings
SymbolCompanyWeight

Annual Performance

Risk Assessment: Peak to Trough